ORNIDYL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ornidyl, and what generic alternatives are available?
Ornidyl is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in ORNIDYL is eflornithine hydrochloride. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the eflornithine hydrochloride profile page.
Summary for ORNIDYL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 88 |
Clinical Trials: | 2 |
Patent Applications: | 4,132 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ORNIDYL at DailyMed |
Recent Clinical Trials for ORNIDYL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Cancer Institute (NCI) | Phase 2 |
Children's Oncology Group | Phase 2 |
Drugs for Neglected Diseases | Phase 2/Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for ORNIDYL
US Patents and Regulatory Information for ORNIDYL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | ORNIDYL | eflornithine hydrochloride | INJECTABLE;INJECTION | 019879-002 | Nov 28, 1990 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ORNIDYL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | ORNIDYL | eflornithine hydrochloride | INJECTABLE;INJECTION | 019879-002 | Nov 28, 1990 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | ORNIDYL | eflornithine hydrochloride | INJECTABLE;INJECTION | 019879-002 | Nov 28, 1990 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ORNIDYL
See the table below for patents covering ORNIDYL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Belgium | 881208 | ⤷ Try a Trial | |
New Zealand | 197394 | INHIBITION OF PROTOZOAL GROWTH IN ANIMALS WITH CERTAIN-SUBSTITUTED-AMINES OR AMINO ACIDS | ⤷ Try a Trial |
Denmark | 148322 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |